Abstract
Chronic total occlusion plaque modification (CTO-PM) is often used after unsuccessful CTO interventions to facilitate future attempts. We aimed to explore the safety and efficacy of both conventional (CB) and drug-coated balloons (DCB) for CTO-PM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have